Derace L. Schaffer, Director at Altimmune, Inc. (ALT), bought 18,331 shares at $2.12 ($38K) on 2017-11-17, disclosed to the SEC on 2017-11-21.
Open-market purchase of $38k ALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.12 | 6,295 | $13K | 34.9% |
| 2 | $2.07 | 4,800 | $10K | 26.0% |
| 3 | $2.06 | 7,236 | $15K | 39.0% |
| Total | $2.08 avg | 18,331 | $38K | 100% |
| Filing → |
| LNTH | SELL | 2019-04-03 | $244K | — | Filing → |
| ALT | BUY | 2018-01-02 | $375K | — | Filing → |
| ALT | BUY | 2017-12-27 | $352K | — | Filing → |